Our top pick for
Cree Inc is a semiconductors business based in the US. Cree shares (CREE) are listed on the NASDAQ and all prices are listed in US Dollars. Cree employs 3,466 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$85.24|
|52-week range||$60.56 - $129.90|
|50-day moving average||$84.87|
|200-day moving average||$94.69|
|Wall St. target price||$100.55|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-4.67|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-08)||1.89%|
|1 month (2021-09-16)||-3.47%|
|3 months (2021-07-16)||-0.99%|
|6 months (2021-04-16)||-23.95%|
|1 year (2020-10-16)||19.57%|
|2 years (2019-10-16)||79.79%|
|3 years (2018-10-16)||127.06%|
|5 years (2016-10-14)||242.05%|
Valuing Cree stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cree's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Cree's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 7.32. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Cree's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Cree's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $9.3 million.
The EBITDA is a measure of a Cree's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$525.6 million|
|Gross profit TTM||$164.6 million|
|Return on assets TTM||-3.92%|
|Return on equity TTM||-16.23%|
|Market capitalisation||$9.2 billion|
TTM: trailing 12 months
There are currently 12.4 million Cree shares held short by investors – that's known as Cree's "short interest". This figure is 1.6% up from 12.2 million last month.
There are a few different ways that this level of interest in shorting Cree shares can be evaluated.
Cree's "short interest ratio" (SIR) is the quantity of Cree shares currently shorted divided by the average quantity of Cree shares traded daily (recently around 1.9 million). Cree's SIR currently stands at 6.48. In other words for every 100,000 Cree shares traded daily on the market, roughly 6480 shares are currently held short.
However Cree's short interest can also be evaluated against the total number of Cree shares, or, against the total number of tradable Cree shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cree's short interest could be expressed as 0.11% of the outstanding shares (for every 100,000 Cree shares in existence, roughly 110 shares are currently held short) or 0.1078% of the tradable shares (for every 100,000 tradable Cree shares, roughly 108 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Cree.
Find out more about how you can short Cree stock.
We're not expecting Cree to pay a dividend over the next 12 months.
Cree's shares were split on a 2:1 basis on 10 December 2000. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Cree shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Cree shares which in turn could have impacted Cree's share price.
Over the last 12 months, Cree's shares have ranged in value from as little as $60.56 up to $129.9. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cree's is 1.4392. This would suggest that Cree's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Cree, Inc. provides lighting-class light emitting diode (LED) and semiconductor products for power and radio-frequency (RF) applications in the United States, China, Europe, and internationally. It operates in two segments, Wolfspeed and LED Products. The Wolfspeed segment offers silicon carbide (SiC) materials for RF, power switching, gemstones, and other applications. It also provides SiC power device products, including SiC Schottky diodes, metal oxide semiconductor field effect transistors (MOSFETs), power modules, and gate driver boards for electric vehicles, including charging infrastructure, server power supplies, solar inverters, uninterruptible power supplies, industrial power supplies, and other applications. In addition, this segment offers gallium nitride (GaN) die, high-electron mobility transistors (HEMTs), monolithic microwave integrated circuits (MMICs), and laterally diffused MOSFET (LDMOS) power transistors for telecommunications infrastructure, military, and other commercial applications; and custom die manufacturing services for GaN HEMTs and MMICs. The LED Products segment provides blue and green LED chip products for video screens, gaming displays, function indicator lights and automotive backlights, headlamps, and directional indicators.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.